Double label immunohistochemistry
| T–p53 positive | Predicted | T–pRb positive | Predicted | |
|---|---|---|---|---|
| No. p53 positive/no. T positive (%; SD) | No. p53 positive also T positive (% T–pRb positive; SD) | No. pRb positive/no. T positive (%; SD) | No. p53 positive also T positive (% T–pRb positive; SD) | |
| Case 1 overall | 56/173 (33.29%; 6.86) | 34/173 (19.78%; 5.30) | 34/66 (52.42%; 6.70) | 16/66 (24.66%; 11.52) |
| Field 1 | 13/36 | 9/36 | 8/16 | 4/16 |
| Field 2 | 9/23 | 5/23 | 7/12 | 2/12 |
| Field 3 | 10/39 | 6/39 | 7/16 | 3/16 |
| Field 4 | 11/42 | 10/42 | 6/12 | 3/12 |
| Field 5 | 13/33 | 4/33 | 6/10 | 4/10 |
| Case 2 overall | 29/59 (49.19%; 6.70) | 28/59 (48.83%; 8.20) | 22/39 (58.00%; 13.04) | 17/39 (43.21%; 5.44) |
| Field 1 | 4/7 | 3/7 | 3/6 | 3/6 |
| Field 2 | 4/10 | 4/10 | 6/10 | 4/10 |
| Field 3 | 8/15 | 9/15 | 4/5 | 2/5 |
| Field 4 | 8/16 | 7/16 | 4/8 | 4/8 |
| Field 5 | 5/11 | 6/11 | 5/10 | 4/10 |
| Case 3 overall | 13/22 (60.10%; 7.02) | 4/22 (18.05%; 4.38) | 33/37 (89.03%; 10.08) | 12/37 (29.04%; 8.64) |
| Field 1 | 4/7 | 2/7 | 6/6 | 2/6 |
| Field 2 | 2/3 | 1/3 | 9/11 | 5/11 |
| Field 3 | 3/5 | 1/5 | 5/6 | 2/6 |
| Field 4 | 2/4 | 1/4 | 4/5 | 1/5 |
| Field 5 | 2/3 | 1/3 | 9/9 | 3/9 |